XIAP and adrenocortical carcinoma, hereditary: With respect to the relationship of XIAP immunoexpression with patient age and sex in AdCC patients, we detected statistically insignificant differences in XIAP immunoexpression according to patient age and sex, similar to the findings of46 in pancreatic cancer patients.